SE8305390L - Seskviterpenderivat - Google Patents

Seskviterpenderivat

Info

Publication number
SE8305390L
SE8305390L SE8305390A SE8305390A SE8305390L SE 8305390 L SE8305390 L SE 8305390L SE 8305390 A SE8305390 A SE 8305390A SE 8305390 A SE8305390 A SE 8305390A SE 8305390 L SE8305390 L SE 8305390L
Authority
SE
Sweden
Prior art keywords
group
general formula
compound
formula
van
Prior art date
Application number
SE8305390A
Other languages
English (en)
Other versions
SE452008B (sv
SE8305390D0 (sv
Inventor
M Shinohara
H Kaise
Y Nakano
T Izawa
Y Oshiro
W Miyazaki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP52078641A external-priority patent/JPS589114B2/ja
Priority claimed from JP15895977A external-priority patent/JPS5492680A/ja
Priority claimed from JP53014674A external-priority patent/JPS5936913B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8305390L publication Critical patent/SE8305390L/sv
Publication of SE8305390D0 publication Critical patent/SE8305390D0/sv
Publication of SE452008B publication Critical patent/SE452008B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Claims (5)

1. Forfarande for framstallning av en forening som har formeln (I) (I) van i Ri betecknar on vdteatom, en lagre alkylgrupp eller en lagre alkanoylgrupp; R2 och R3, som kan vara lika eller olika, vardera betecknar en formylgrupp, en hydroximetylgrupp, en hydroxylgrupp, en karboxylgrupp, en lagre alkanoy1oximetylgrupp eller en grupp som har formeln -CH.CR7R8, van i R7 och R8, som kan vara lika eller olika, vardera betecknar en vateatom, en cyanogrupp, en lggre alkoxikarbonylgrupp eller en karboxylgrupp, eller van i R2 och R3 kan kombineras och bilda R9 0 en laktonring som har formeln van i R9 betecknar en vateatom eller en hydroxylgrupp; R4 och R6, som kan vara lika eller olika, vardera betecknar en hydroxylgrupp eller en lagre alkanoyloxigrupp; 115 betecknar en vateatom; R4 och R5 tillsammans kan bilda en oxogrupp; och R4 och R6 kan kombineras till att bilda en lagre alkylidendioxigrupp; samt de farmaceutiskt godtagbara salterna darav,kannetecknat ddrav, att man (1) ear man framstaller en forening med den allmanna formeln (I), van i 112, R3 eller bada betecknar en hydroximetylgrupp, reducerar formylgrupperna i en forening, som har den allmanna formeln (I), van i R
2. , R3 eller bada betecknar en formylgrupp eller reducerar en fOrening, som har den allmanna formeln (I), van i 02 och R3 Or bundna till varandra till bild- R9 0 ning av en laktonring som has formeln van i R9 har den ovan angivna betydelsen; (2) vid framstallning av en fbrening som har den allmanna formeln (I), van i R2 och R3 Or bundna till varandra och 0 bildar en laktonring med formeln cykliserar man under frig-6ring av vatten en forening som har den allmanna formeln (I an endera • och R
3. Or en hydroximetylgrupp och den a en karboxyl (Aar man framstaller en fOrening som har den allmanna formeln (I), van i R2, R3 eller hada betecknar en grupp corn har formeln -CH=CR7R8, van i R7 och R8 har den ovan angivna betydelsen, dehydrokondenserar man en forening, som har den allmanna formeln (I), vari R2, R3 eller bada betecknar en formylgrupP, med en aktiv metylenforening, som har den allmanna formeln (II): R7 H 2 van i R7 och R8 har oven angiven betydelse, i narvaro av en kata/ysator:
4. nar man framstaller en fOrening scm har den all-manna formeln (I), van i R2, R3 eller bada betecknar en hydroxylgrupp, bringar man en forening, som har den allmanna formcln (I), van i R2, R3 eller bada betecknar en formylgrupp, att reagera med en peroxid i ett inert 18sningsmedel; eller
5. nar man framstaller en fOrening som her den all-manna formeln (T), vari 52, R3 eller bide betecknar en lagre alkanoyloximetylgrupp, acylerar man en forening, som her den allmanna formeln (I), van i R2, R3 eller bada betecknar en hydroximetylgrupp; och, em 58 Onskas, omvandlar man produkten i wart och ett av fallen (1) - (5) till de farmaceutiskt godtagbara salterna darav.
SE8305390A 1977-06-30 1983-09-30 Forfarande for framstellning av seskviterpenderivat SE452008B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP52078641A JPS589114B2 (ja) 1977-06-30 1977-06-30 セスキテルペン類縁体、その製造法及び腎炎治療剤
JP15895977A JPS5492680A (en) 1977-12-29 1977-12-29 Novel microorganism
JP53014674A JPS5936913B2 (ja) 1978-02-10 1978-02-10 セスキテルペン誘導体

Publications (3)

Publication Number Publication Date
SE8305390L true SE8305390L (sv) 1983-09-30
SE8305390D0 SE8305390D0 (sv) 1983-09-30
SE452008B SE452008B (sv) 1987-11-09

Family

ID=27280728

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7805606A SE439322B (sv) 1977-06-30 1978-05-16 Forfarande for framstellning av seskviterpenderivat genom odling av en mikroorganism tillhorande slektet stachybotrys
SE8305390A SE452008B (sv) 1977-06-30 1983-09-30 Forfarande for framstellning av seskviterpenderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7805606A SE439322B (sv) 1977-06-30 1978-05-16 Forfarande for framstellning av seskviterpenderivat genom odling av en mikroorganism tillhorande slektet stachybotrys

Country Status (17)

Country Link
US (1) US4229466A (sv)
AR (1) AR228011A1 (sv)
CA (1) CA1142106A (sv)
CH (1) CH641452A5 (sv)
DE (1) DE2821403C2 (sv)
DK (2) DK154704C (sv)
ES (2) ES469821A1 (sv)
FR (1) FR2405941A1 (sv)
GB (1) GB1601479A (sv)
IE (1) IE46785B1 (sv)
IT (1) IT1103138B (sv)
MX (1) MX6053E (sv)
NL (1) NL181804C (sv)
NO (2) NO152220C (sv)
NZ (1) NZ187243A (sv)
PT (1) PT68035B (sv)
SE (2) SE439322B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5630917A (en) * 1979-08-22 1981-03-28 Otsuka Pharmaceut Co Ltd Preventive and remedy for hepatitis
US4423027A (en) * 1982-12-22 1983-12-27 Simon Lionel N Pharmaceutical compositions of deglycyrrhizinated licorice (DGL)
JPS6193179A (ja) * 1984-10-15 1986-05-12 Takara Shuzo Co Ltd グアニジルフンジン類の誘導体及びその製造方法
JPS646214A (en) * 1987-02-13 1989-01-10 Otsuka Pharma Co Ltd Remedy for ulcerative colonopathy
US5506247A (en) * 1988-04-15 1996-04-09 T Cell Sciences, Inc. Compounds that inhibit complement and/or suppress immune activity
US5173499A (en) * 1988-04-15 1992-12-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US5366986A (en) * 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US4981980A (en) * 1989-09-14 1991-01-01 Merck & Co., Inc. Drug for treating manic depression
EP0447813A1 (en) * 1990-02-28 1991-09-25 GRUPPO LEPETIT S.p.A. Water soluble salts of purpuromycin and pharmaceutical formulations thereof
US5532416A (en) * 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE69509643T2 (de) * 1994-03-25 1999-10-14 Gruppo Lepetit S.P.A. Sesquiterpenderivate
US5869688A (en) * 1994-07-20 1999-02-09 Monsanto Company Preparation of substituted 3-aryl-5-haloalkyl-pyrazoles having herbicidal activity
US5698708A (en) * 1996-06-20 1997-12-16 Monsanto Company Preparation of substituted 3-aryl-5-haloalkyl-pyrazoles having herbicidal activity
JP4194196B2 (ja) * 1999-02-22 2008-12-10 花王株式会社 浴用剤組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985896A (en) * 1975-07-15 1976-10-12 Smithkline Corporation Benzophenalenofurans
US4046805A (en) * 1976-05-10 1977-09-06 American Cyanamid Company Substituted-hydroxy-naphthalenedisulfonic acid compounds

Also Published As

Publication number Publication date
DK212778A (da) 1978-12-31
NO781704L (no) 1979-01-03
FR2405941A1 (fr) 1979-05-11
SE7805606L (sv) 1979-01-08
NL7805160A (nl) 1979-01-03
NL181804C (nl) 1987-11-02
NO834363L (no) 1979-01-03
CH641452A5 (de) 1984-02-29
MX6053E (es) 1984-10-16
DE2821403C2 (de) 1984-01-26
ES477771A1 (es) 1979-12-01
ES469821A1 (es) 1979-09-16
IE46785B1 (en) 1983-09-21
PT68035B (en) 1979-10-24
GB1601479A (en) 1981-10-28
CA1142106A (en) 1983-03-01
DE2821403A1 (de) 1979-01-25
IT1103138B (it) 1985-10-14
NL181804B (nl) 1987-06-01
SE452008B (sv) 1987-11-09
SE439322B (sv) 1985-06-10
NO152220B (no) 1985-05-13
NZ187243A (en) 1984-07-31
DK58487D0 (da) 1987-02-04
SE8305390D0 (sv) 1983-09-30
US4229466A (en) 1980-10-21
IT7849342A0 (it) 1978-05-15
DK154704C (da) 1989-05-08
IE780975L (en) 1978-12-30
DK154704B (da) 1988-12-12
AR228011A1 (es) 1983-01-14
DK155670B (da) 1989-05-01
DK155670C (da) 1989-09-18
PT68035A (en) 1978-05-31
DK58487A (da) 1987-02-04
NO154013C (no) 1986-07-02
NO152220C (no) 1985-08-21
NO154013B (no) 1986-03-24
FR2405941B1 (sv) 1983-02-04

Similar Documents

Publication Publication Date Title
SE8305390L (sv) Seskviterpenderivat
IE37046L (en) IMIDAZO [5,1-f]-as-TRIAZINES
SE8000110L (sv) Omettade tio-derivat av 7-acetamido-3-cefem-4-karboxylsyra och forfarande for framstellning av dem
GB1507957A (en) Nitrofuryl-pyrazole derivatives methods for producing them and medicaments comprising them
ES453161A1 (es) Un procedimiento de preparacion de espiro (1,3-dioxolan-4,3)quinuclidinas.
IE42957L (en) Rosamicin (antibiotic 67-694) derivatives.
IE37007L (en) Antiallergic tricyclic compounds
ES406320A1 (es) Un procedimiento para la preparacion de oxido de 8,14-ce- drano.
AU5490280A (en) Prostacyclin
JPS5259186A (en) Preparation of 3-cephem compounds by reduction
SE8302517L (sv) Forfarande for framstellning av antibiotikum c-15003 p-0 (maytansinol)
IE35441L (en) Phosphoric acid esters
JPS5279082A (en) Preparation of anti-tumor compound
SE7706083L (sv) Bicykliska laktondiolderivat jemte sett for deras framstellning
JPS52211A (en) Process for preparatiopn of epoxides
JPS51125358A (en) Process for preparing 2,i-dimethyl-3- (2,2-dihalovinyl)-cyclopropaneca rboxylic acid derivatives
JPS5414951A (en) Preparation of vitamin d derivatives
JPS5231090A (en) Preparation of 3-substitutedmethyl-3- cephem derivatives
IE46007L (en) Salts of 2-phenyl-5 hydroxy-alkanoic acids
JPS51125798A (en) Process for preparing a new antibiotic, sf-1739 substance
JPS5419985A (en) Production of hydroxycarbostyril derivative
JPS524884A (en) Acceleration detector
IE43378L (en) 6-[ó-amino-omega-(2,3-or 3,4-methylenedioxyphenyl)-acylamido]¹penicillanic acid derivatives
JPS51118757A (en) Process for preparation of dibenzofuran-2,7-dicarboxylic acid
JPS51136661A (en) Process for preparing 7-dehydrocholesterols.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305390-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305390-0

Format of ref document f/p: F